Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devaki R Nair

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 20, 2015
Strategies to overcome statin intoleranceAris P Agouridis, Devaki R Nair, Dimitri P Mikhailidis
Current Pharmaceutical Design|November 10, 2015
All for Statins and Statins for All; An UpdateAris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
Family Practice|May 1, 2013
Cardiovascular risk assessment of South Asian populations in religious and community settings: a qualitative studySophie V Eastwood, Greta Rait, Mimi Bhattacharyya, et al.
Current Medical Research and Opinion|August 19, 2007
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statinIrene F Gazi, Stella S Daskalopoulou, Devaki R Nair, et al.
Archives of Medical Science : AMS|January 21, 2016
Ear lobe crease: a marker of coronary artery disease?Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
The Open Cardiovascular Medicine Journal|July 3, 2009
Kidney function and estimated vascular risk in patients with primary dyslipidemiaKonstantinos Tziomalos, Emmanuel S Ganotakis, Irene F Gazi, et al.
Annals of Clinical Biochemistry|July 17, 2016
Evaluation of the point of care Afinion AS100 analyser in a community settingAnjly Jain, Nandini Rao, Mahtab Sharifi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemiaEmmanuel S Ganotakis, Irene F Gazi, John A Papadakis, et al.
Clinical Biochemistry|March 2, 2016
Molecular analysis of the LDLR gene in coronary artery disease patients from the Indian populationK N ArulJothi, R A Whitthall, M Futema, et al.
In Vivo (Athens, Greece)|August 22, 2007
Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equationEmmanuel S Ganotakis, George E Vrentzos, Irene F Gazi, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Metabolism & Toxicology|March 20, 2015
Strategies to overcome statin intoleranceAris P Agouridis, Devaki R Nair, Dimitri P Mikhailidis
Current Pharmaceutical Design|November 10, 2015
All for Statins and Statins for All; An UpdateAris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
Family Practice|May 1, 2013
Cardiovascular risk assessment of South Asian populations in religious and community settings: a qualitative studySophie V Eastwood, Greta Rait, Mimi Bhattacharyya, et al.
Current Medical Research and Opinion|August 19, 2007
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statinIrene F Gazi, Stella S Daskalopoulou, Devaki R Nair, et al.
Archives of Medical Science : AMS|January 21, 2016
Ear lobe crease: a marker of coronary artery disease?Aris P Agouridis, Moses S Elisaf, Devaki R Nair, et al.
The Open Cardiovascular Medicine Journal|July 3, 2009
Kidney function and estimated vascular risk in patients with primary dyslipidemiaKonstantinos Tziomalos, Emmanuel S Ganotakis, Irene F Gazi, et al.
Annals of Clinical Biochemistry|July 17, 2016
Evaluation of the point of care Afinion AS100 analyser in a community settingAnjly Jain, Nandini Rao, Mahtab Sharifi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemiaEmmanuel S Ganotakis, Irene F Gazi, John A Papadakis, et al.
Clinical Biochemistry|March 2, 2016
Molecular analysis of the LDLR gene in coronary artery disease patients from the Indian populationK N ArulJothi, R A Whitthall, M Futema, et al.
In Vivo (Athens, Greece)|August 22, 2007
Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equationEmmanuel S Ganotakis, George E Vrentzos, Irene F Gazi, et al.
Pageof 4